-
Health Technologies Using Artificial Intelligence: What Is Being Assessed in the UK by NICE?
Sep 9, 2025, 16:22 PM -
Applying Simulation-Guided Trial Design Principles to Prospectively Plan Target Trial Emulation of a Cluster Randomized Trial for Vaccine Coverage
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Iptacopan vs. C5 Inhibitors in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Naïve to Complement Inhibitors in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Fecal Microbiota Transplantation for Irritable Bowel Syndrome With Constipation: A Decision-Analytical Analysis
Sep 9, 2025, 16:22 PM -
Are Women’s Health Strategies Driving Change? A Review of NICE and SMC HTAs
Sep 9, 2025, 16:22 PM -
Data Reliability in Retrospective Chart Review Studies: Results and Considerations From a Novel Data Review Methodology
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Strategies to Prevent Respiratory Syncytial Virus Infections Among Infants in Ireland
Sep 9, 2025, 16:22 PM -
Cross-Validation of the Glycated Hemoglobin HbA1c Translator: A Predictive Tool to Evaluate the Relationship Between Diabetes Complications and Associated Healthcare Costs
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of High-Dose Trivalent Influenza Vaccine in the Elderly: A Cohort-Based Economic Model From the Italian NHS Perspective
Sep 9, 2025, 16:22 PM -
The Intercept of Real-World Evidence (RWE) Health Equity and Health Technology Assessment (HTA): A Structured Literature Review of Health Policy and Methodological Guidance
Sep 9, 2025, 16:22 PM -
Modeling Physician Prescribing Decisions Based on Patient Characteristics for Positioning of a Novel Treatment Entering a Well-Established Category
Sep 9, 2025, 16:22 PM -
Food and Health Literacy Among University Students: Sociodemographic Insights
Sep 9, 2025, 16:22 PM -
The Impact of Real-World Standard-Dose Influenza Vaccine Effectiveness on the Cost-Effectiveness of High-Dose Influenza Vaccine: A Case Study in Japan
Sep 9, 2025, 16:22 PM -
Evaluating Treatment Benefit and Tolerability Based on Responder and Time-to-Event Analysis of Patient-Reported Outcomes in Cancer Clinical Trials: A Scoping Review
Sep 9, 2025, 16:22 PM -
Subsequent Treatments and NICE Appraisals for DLBCL: A Review of Committee Discussions
Sep 9, 2025, 16:22 PM -
Development of a Content-Valid Patient-Reported Outcome (PRO) Measure for Adults With Glycogen Storage Disease Type 1a (GSD1a): The GSD1a Symptom Diary-Adult Version
Sep 9, 2025, 16:22 PM -
Impact of Proteinuria and Declining Kidney Function on the Healthcare Resource Utilization and Associated Costs of Patients With IgA Nephropathy: A Retrospective Analysis in the UK and Spain
Sep 9, 2025, 16:22 PM -
Elevating the Patient Perspective: Quantifying First-Line Preferences in Locally Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) Using the Threshold Technique
Sep 9, 2025, 16:22 PM -
Improving the Transferability of Global RCT Data to Inform Cost-Effectiveness Models in Japan: A Structured Framework for C2H Submissions
Sep 9, 2025, 16:22 PM -
The Changing Prevalence of Multicomorbid Patients in the US
Sep 9, 2025, 16:22 PM
